Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Pharma Grade Cellulose Powder Market Expansion Outlook: What Revenue Opportunities Are Ahead?
The pharma grade cellulose powder market has witnessed strong expansion over recent years. It is projected to increase from $1.55 billion in 2025 to $1.65 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.1%. Historically, this market’s growth can be attributed to an upsurge in oral drug formulations, the widespread adoption of cellulose excipients, the broadening scope of pharmaceutical manufacturing, the necessity for formulation stability, and the regulatory approval of cellulose-based excipients.
The market for pharma grade cellulose powder is projected to experience robust expansion over the coming years, reaching a valuation of $2.09 billion by 2030, driven by a compound annual growth rate (CAGR) of 6.1%. This anticipated growth during the forecast period is fueled by several factors, including the expanding use in nutraceutical applications, the increasing need for clean-label excipients, the development of generic drug pipelines, innovations in excipient engineering, and stricter sustainability mandates. Key trends emerging during this timeframe encompass a rising preference for plant-based pharmaceutical excipients, broader application in solid oral dosage forms, increasing uptake of microcrystalline cellulose, the proliferation of multi-functional cellulose excipients, and a heightened emphasis on sustainable excipient procurement.
Get A Free Sample Report With In-Depth Market Insights:
Pharma Grade Cellulose Powder Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
The increasing output from pharmaceutical production is anticipated to drive the expansion of the pharma-grade cellulose powder market moving forward. Pharmaceutical production involves the creation of medicines through the formulation, synthesis, and meticulous quality control of active ingredients and excipients, ensuring safety, effectiveness, and adherence to regulatory standards. The growth in pharmaceutical production is attributed to the increase in chronic diseases, which necessitate continuous and long-term medication for their effective management. Pharma-grade cellulose powder plays a supportive role in pharmaceutical production by acting as a reliable binder, filler, and stabilizer, which helps in maintaining tablet integrity and guaranteeing uniform drug distribution. For instance, in June 2023, as per the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association representing Europe’s pharmaceutical industry, the total pharmaceutical production in Europe reached $422,803 million (€390,000 million) in 2023, an increase from $393,857 million (€363,300 million) in 2022. Thus, the escalating pharmaceutical production is fueling the growth of the pharma-grade cellulose powder market.
Pharma Grade Cellulose Powder Market Segment Breakdown: Which Categories Lead On Revenue?
The pharma grade cellulose powder market covered in this report is segmented –
1) By Product Type: Microcrystalline Cellulose (MCC), Carboxymethyl Cellulose (CMC), Hydroxypropyl Methylcellulose (HPMC), Hydroxypropyl Cellulose (HPC)
2) By Functionality: Binding Agent, Thickening Agent, Stabilizer, Disintegrant, Coating Agent
3) By Application: Pharmaceuticals, Nutraceuticals, Cosmetics, Other Applications
4) By End-User: Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic And Research Institutions, Manufacturers Of Dietary Supplements, Food And Beverage Industries
Subsegments:
1) By Microcrystalline Cellulose: Powder, Granules
2) By Carboxymethyl Cellulose (CMC): Sodium Carboxymethyl Cellulose (CMC), Calcium Carboxymethyl Cellulose (CMC), Other Carboxymethyl Cellulose (CMC) Variants
3) By Hydroxypropyl Methylcellulose (HPMC): Low Viscosity Hydroxypropyl Methylcellulose (HPMC), Medium Viscosity Hydroxypropyl Methylcellulose (HPMC), High Viscosity Hydroxypropyl Methylcellulose (HPMC)
4) By Hydroxypropyl Cellulose: Low Substitution Hydroxypropyl Cellulose (HPC), High Substitution Hydroxypropyl Cellulose (HPC)
Pharma Grade Cellulose Powder Market Innovation Trends Shaping Future Development
Leading enterprises in the pharma-grade cellulose powder market are concentrating on establishing new microcrystalline cellulose facilities to boost their production capacity and reinforce supply chain capabilities for pharmaceutical excipients. A microcrystalline cellulose facility is a specialized site where purified cellulose undergoes precise chemical and mechanical treatments to yield uniform, fine-grade particles suitable for pharmaceutical applications. For instance, in September 2023, Nitika Pharmaceuticals Specialties, an India-based excipient manufacturing company, unveiled Tabcell, India’s largest microcrystalline cellulose (MCC) manufacturing plant located in Nagpur. This cutting-edge plant, with an installed capacity of 1200 metric tons, was inaugurated by Union Minister Nitin Gadkari and marks a significant achievement under the Government of India’s Production Linked Incentive (PLI) scheme for excipients. The new facility bolsters Nitika Pharma’s status as a global leader in pharmaceutical excipients, supporting both domestic requirements and exports to over 92 countries, while also contributing to the “Make in India” initiative and generating substantial local employment opportunities.
Pharma Grade Cellulose Powder Market Leading Players And Competitive Positioning
Major companies operating in the pharma grade cellulose powder market are Roquette Frères, Ashland Global, JRS Pharma, DFE Pharma, Sigachi Industries Ltd., Accent Microcell Ltd., FMC Corporation, Dow Chemical Company, Shin-Etsu Chemical Co. Ltd., Colorcon, Nippon Paper Industries Co. Ltd., Rayonier Advanced Materials, Lotte Fine Chemical, Mingtai Chemical Co. Ltd., Weifang Lude Chemical Co. Ltd., Shandong Head Co. Ltd., Zhejiang Kehong Chemical Co. Ltd., Anhui Sunhere Pharmaceutical Excipients Co. Ltd., Maple Biotech Pvt. Ltd., Ankit Pulps & Boards Pvt. Ltd.
View The Full Pharma Grade Cellulose Powder Market Report:
Pharma Grade Cellulose Powder Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the pharma-grade cellulose powder market in 2025. The regions covered in the pharma grade cellulose powder market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
